Using the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry, we captured 1319 diabetics with multivessel disease requiring revascularization for an acute coronary syndrome (January 2009-December 2012) and reported health status using the Seattle Angina Questionnaire (SAQ) at baseline, 1, 3 and 5-years [599 underwent coronary artery bypass grafting (CABG); 720 underwent percutaneous coronary intervention (PCI)]. Adjusted analyses were performed using a propensity score-matching technique. After adjustment (including baseline SAQ domain scores), 1-year mean (95% CI) SAQ scores (range 0-100 with higher scores reflecting improved health status) were significantly greater in selected domains for CABG compared to PCI (exertional capacity: 81.7 [79. 5- 
.. Conclusion
Improvements in health status with CABG compared with PCI were not sustained long-term. This temporal sequence should be considered when contemplating a revascularization strategy in diabetics with multivessel disease. 
Introduction
Despite contemporary advances in prevention and treatment, coronary artery disease (CAD) remains a major contributor to morbidity and mortality worldwide. 1 Moreover, diabetes mellitus (DM) has long been recognized as a major risk factor for CAD with greater disease burden, doubling of age-adjusted prevalence, and 2-4 times higher risk of death.
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When revascularization is contemplated, coronary artery bypass grafting (CABG) surgery compared to percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) in diabetics with multivessel disease. 6, 7 As such, guideline recommendations support CABG over PCI in this population subset. [8] [9] [10] [11] Most recently, the Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial found a reduction in all-cause death, non-fatal MI or non-fatal stroke in favour of CABG compared with PCI. 12 Additionally, a prespecified sub-group analysis demonstrated improved health status (including quality of life [QOL]) with CABG surgery. 13 However, the magnitude of benefit was not addressed long term. Knowledge in this domain becomes important as the quality of life may influence decisions regarding mode of revascularization in patients where survival becomes less important (i.e. the elderly). Accordingly, we examined the relationship between revascularization technique and health status (including QOL) in diabetics with multivessel disease over a 5-year period.
Methods

Data source
The Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry is a prospective clinical data collection initiative capturing information on all patients undergoing cardiac revascularization in Alberta, Canada since 1995. APPROACH presently has over 200 000 patients followed in this registry. 14 As well, it is used as the patient chart data for all catheterizations, PCI and CABG performed. However, in order to ensure data quality and completeness, clinical data from the registry are merged annually with administrative data using previously published methodology. 15 This 'enhanced' file is then used in all study analyses. The APPROACH database contains detailed demographic and clinical data as well as tracking data on therapeutic interventions and revascularization procedures. APPROACH captures data on patient age, sex, ejection fraction, presence or absence of previous MI, congestive heart failure, comorbid medical conditions as well as previous therapeutic interventions such as medications, fibrinolytic therapy, revascularization approach (i.e. CABG or PCI). Regarding coronary catheterization and revascularization, APPROACH also captures coronary anatomy and procedural data. Cardiovascular health status in the APPROACH database is measured using the well-validated Seattle Angina Questionnaire (SAQ). [16] [17] [18] [19] The baseline survey is sent to patients within 1 month of their index cardiac catheterization, followed by subsequent surveys at 1, 3, and 5 years on the anniversary of their index catheterization. The completed questionnaire can be returned by mail or patients can call a toll-free line and respond to the verbally administered survey, which is recorded and transcribed daily. A second (and third) questionnaire is sent to non-respondents at 2-month intervals.
Patients
Using the APPROACH registry, we identified a contemporary population of 1319 diabetic patients with multivessel CAD who present with an acute coronary syndrome (ACS) prompting coronary revascularization (n = 599 CABG; n = 720 PCI) from January 2009 to December 2012 and had reported health status outcomes at baseline, 1, 3, and 5 years (minimum 3 year follow-up). Patients who died during this time period were excluded as they would not be given the chance to complete serial SAQs.
Measurement of health status
Health status outcomes in APPROACH were collected using the SAQ self-reported questionnaire. The SAQ is a 19-item, self-administered disease-specific questionnaire measuring five dimensions of health status: exertional capacity, anginal stability, anginal frequency, treatment satisfaction, and quality of life, generating five independent scales. Details of the questions asked in the SAQ can be found in the Supplementary index. Each question is measured on an ordinal scale from 1 to 5 (6 for the anginal frequency scale), with 1 indicating the lowest/poorest response and 5/6 indicating the highest/best response. The SAQ has been judged to be a valid, responsive and reliable instrument. 15 In addition, the SAQ is sensitive to changes in a patient's clinical status over time as it focuses on symptoms and impairments in health that are unique to coronary disease.
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Statistical analysis
The SAQ scores are summed across items within each of the five dimensional scales. As suggested by the developers, scale scores are transformed to a 0-100 range (with 0 reflecting the lowest/poorest response and 100 reflecting the highest/best response) by subtracting the lowest possible score, dividing by the range of the scale and multiplying by 100. 16, 17 As each of the scales monitor a unique dimension of CAD, no summary score is generated. Baseline variables were compared using v 2 tests for categorical data and t-tests for continuous data between CABG and PCI treated patients with diabetes and multivessel disease. The Rosenbaum and Rubin propensity-score matching technique was used to obtain a comparable distribution of demographic, comorbid and clinical variables between both groups. 20 The propensity score was calculated as the probability of having had a CABG conditional on the observed baseline (measured at catheterization) characteristics. This technique allows for a high number of confounding variables and has been used to create a stratum of subjects who can be matched on the propensity score whereby exposure (i.e. CABG or PCI) is not confounded with measured baseline covariates. The propensity score was calculated using logistic regression. The following variables were included in the model: age, sex, pulmonary disease, cerebrovascular disease, renal disease, heart failure, present smoker, past smoker, dialysis, hypertension, hyperlipidemia, liver/gastrointestinal disease, malignancy, peripheral vascular disease, prior myocardial infarction (MI), prior PCI, prior CABG, prior fibrinolytic therapy (during index admission), the indication for catheterization including MI or unstable angina, the coronary anatomy, and the ejection fraction. Greedy matching techniques were applied to match patients who were treated with CABG to patients whose index treatment was PCI by matching the participants with the nearest propensity score (i.e. within two decimal places of the propensity score) for each case. Overlap of propensity scores between CABG and PCI patients were evaluated using histograms, v 2 values and probability values. Differences in baseline factors between groups were calculated before and after propensity adjustment to assess balance. Following the match, t-tests were used to determine if there were 
Results
As seen in Figure 1 , a total of 22 794 patients with multi-vessel CAD undergoing revascularization for ACS were identified. Of these, 5722 patients had diabetes and 1319 of those patients had SAQ outcomes at 1, 3, and 5 years (PCI N = 720; CABG N = 599). The median time (and interquartile range) for return of the SAQ responses were at baseline 32 (18-51) days, at 1 year 19 (14-29) days, at 3 years 20 (14-29) days and at 5 years 18 (14-28) days. Median times to CABG and PCI were 10.6 days and 0.63 days, respectively, following index cardiac catheterization. Repeat revascularization rates were 25.5% (N = 336) over a 5-year period with PCI being used most commonly (80.1%). Of the CABG-treated patients, 9.7% (N = 58) required repeat revascularization with PCI used in all cases. A minority of these patients received repeat revascularization within the first year (20.7%). Of the PCI treated patients, 38.6% (N = 278) required repeat revascularization with PCI used in the majority of cases (PCI: N = 211; CABG: N = 67). Roughly, one-half of these patients received repeat revascularization within the first year (44.6%). It is worthy to note that a minority of patients completed all questionnaires out to 5 years. When performing a comparator analysis between survey responders and non-responders, non-responders were significantly more likely to be women, current smokers, on dialysis, and have cerebrovascular disease, congestive heart failure, and/ or peripheral vascular disease (data not shown). Table 1 outlines the unadjusted demographic and baseline characteristics according to the revascularization strategy. CABG patients compared with PCI were more likely to be older in age, male and have comorbid cardiovascular conditions such as congestive heart failure and peripheral vascular disease but less likely to be obese or suffer from dyslipidemia. Anatomically, CABG patients had a greater burden of CAD with left mainstem involvement. Table 2 represents the unadjusted mean heath status scores at baseline, 1, 3, and 5 years in DM patients with multivessel CAD according to CABG or PCI. Diabetic patients who underwent CABG report significantly worse health status across all five SAQ domains at baseline relative to the PCI-treated group. At 1 year of follow-up, the CABG-treated group reports significantly better health status in terms of angina stability, angina frequency, treatment satisfaction as well as QOL compared with the PCI-treated patients. With the exception of improved angina stability at 3 years for CABG-treated patients, similar health status and QOL between CABG vs. PCI were observed long term. Table 3 shows the baseline characteristics for the propensitymatched diabetic patients receiving revascularization (N = 732). Propensity adjustment yielded excellent balance between the PCI and CABG groups as the standardized difference was well below the recommended maximum value of 10% for every risk factor (data not shown). As seen in Figure 2 , CABG-treated patients report significant improvements in most domains when compared to PCI-treated patients at 1 year (exertional capacity: 81.7 [79. 5- (Figure 2 ).
Unadjusted outcomes
Propensity-matched outcomes
Mean differences of health status domains adjusted for baseline status are reported in Table 4 . At 3-5 years all domains appear similar with the exception of angina frequency, which appears to favour CABG. However, the numeric improvement in angina frequency at 5 years is not felt to be a meaningful difference to alter clinical practice (i.e. <8-10 points). 21 While the majority of patients in both groups reported no angina, significantly more patients in the PCI-treated group experienced angina at 1 year compared with CABG ( Figure 3A) . However, there was no statistical difference between treatment groups in the number of patients reporting angina at 3 or 5 years ( Figure 3B and C) . More importantly, a large majority of patients are angina free at 5 years irrespective of revascularization choice ( Figure 3C ).
Discussion
Our study, derived from a large comprehensive clinical registry, provides new insight into domains of health status (including QOL) of diabetics with multivessel disease undergoing revascularization for ACS. Regardless of revascularization strategy, both groups report Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease improvements in health status that endure long-term, with the vast majority remaining angina-free at 5 years of follow-up. We did observe early benefits of CABG over PCI; however, this is not sustained long-term with both groups reporting similar health status at 3-5 years. Reassuringly, revascularization in diabetic multivessel disease improves health status irrespective of strategy selected (CABG or PCI). Similar findings were reported from the FREEDOM QOL sub-study (measured using the SAQ and Rose Dyspnoea Scale). 13 In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI-2D) trial, improvements in health status (measured by the Duke Activity Status Index) was observed with prompt revascularization (CABG or PCI) compared with intensive medical therapy alone. These benefits were seen early and maintained at a 4-year follow-up. 22 Our results are congruent with these findings and help support revascularization in such patients.
Analysis of baseline survey results (within one month following index cardiac catheterization) consistently found improved domains of health status (including QOL) with PCI compared to CABG as the mode of revascularization. It is conceivable this difference is attributed to the surgical wait time for CABG compared with more timely access with PCI. 23 Conversely, the early post-operative recovery period may negatively impact patients' health status with CABG. 24 Therefore, we adjusted for baseline differences in mean SAQ scores. At 1 year, CABG-treated patients showed greater improvement over PCI across most SAQ domains. Although speculative, this in part may be due to the influence of 'complete revascularization' with CABG compared with 'incomplete revascularization' with PCI at 1 year. 25 To add, the incidence of in-stent restenosis is greatest within the first year of PCI, 26, 27 hence recurrent symptoms are more likely to occur during this time interval leading to higher rates of repeat revascularization with PCI. In our study, we found roughly 50% of repeat revascularization occurred within the first year following PCI as opposed to CABG which was less likely to occur. Moreover, previous studies have documented a relationship between repeat revascularization and altered health status. 28, 29 Longer term (3-5 years), the majority of SAQ domains appear similar between either revascularization strategy. It is conceivable the extended advantages of evidence-based secondary prevention therapies may be more prevalent in PCI since CABG patients are less likely to be prescribed (or use) medications. [30] [31] [32] [33] Moreover, acceleration of vein graft disease becomes more apparent resulting in recurrent symptoms and subsequent vein graft occlusion. 34 In our study, the majority of repeat revascularization in CABG patients occurred after the first year. Additionally, improvements in stent technology seen with second-generation drug-eluting stents (i.e. superior long-term efficacy >1 year) may help mitigate long-term benefits with CABG. 35 Interestingly, our results are congruent with the 'longer-term' FREEDOM QOL results which report similar patient-reported outcomes beyond 2-years. 13 In our study, we did observe improved angina frequency with CABG compared with PCI at 5-years; however, the absolute difference was small with limited clinical relevance (i.e. the numeric improvement is not a meaningful clinical difference). 21 Moreover, the majority of patients in both revascularization groups remain angina free out to 5 years. Overall, the similar domains of health status including QOL between CABG and PCI longer term provide patients and clinicians a viable option with PCI in patients where 3-5 year health status may be surmountable over survival (recognizing the 1-year health status advantage with CABG) and peri-procedural risk with CABG surgery may be of concern (i.e. the elderly). Hence, our results support the continued effort to help 'bridge the gap' between CABG and PCI in diabetic patients.
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Study limitations
We do recognize limitations of our study, which warrant discussion. First, our study did not take into account the type of stent utilized in the PCI-treated group. However, during this contemporary time period, it is a common practice to use second-generation drug-eluting stents (particularly in diabetic patients). Second, collection of medications long-term was incomplete and could not be accurately reported. Third, domains of health status including QOL were assessed using a disease-specific rather than a generic assessment tool. While the SAQ has greater sensitivity for changes in health status due to CAD, it may underestimate the impact of other outcomes such as stroke which would be more common following revascularization with CABG. Fourth, the impact of procedural complications, re-admissions or completeness of revascularization on health status could not be explored. Fifth, a large number of patients did not respond to the SAQ with complete 5-year data. These patients had greater comorbidites precluding them from completing SAQ's longterm. It is unclear if this would have influenced the outcome as these patients-if included-would have been propensity matched between groups as well. Sixth, we found majority of patients were angina free at 5 years irrespective of revascularization modality. Although speculative, it is conceivable these results may be different if patients presented with stable angina as opposed to ACS. Finally, we could not fully account for the possible influence of SAQ administration on the patient-reported results. Mode of administration (e.g. self-completion or interviewer-administered) has been shown to influence response rates, questionnaire completeness and the nature of responses.
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Conclusions
In summary, diabetic patients with multivessel disease undergoing revascularization for ACS report sustained improvements in all domains of health status including QOL. Benefits with CABG compared with PCI were observed at 1 year; however, these gains appear to attenuate long term. Moreover, majority of patients are angina-free regardless of revascularization strategy employed. Our findings should be considered as a part of the armamentarium in the decision process for revascularization (CABG vs. PCI) in diabetics with multivessel CAD.
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